X0306 4 2018-07-24 0001398733 Aquestive Therapeutics, Inc. AQST 0001281933 BRATTON DOUGLAS K 201 MAIN STREET SUITE 1900 FORT WORTH TX 76102 1 0 1 0 0001747211 Monoline Partners, L.P. C/O BRATTON CAPITAL MANAGEMENT 201 MAIN STREET, SUITE 1900 FORT WORTH TX 76102 0 0 1 0 0001723787 Bratton Capital Management, L.P. 201 MAIN STREET SUITE 1900 FORT WORTH TX 76102 0 0 1 0 0001723783 Bratton Capital Inc. 201 MAIN STREET SUITE 1900 FORT WORTH TX 76102 0 0 1 0 Common Stock 2018-07-24 4 P 0 165000 15.00 A 165000 I See Footnotes Common Stock 75085 D Common Stock 2249077 I See Footnotes Common Stock 2213314 I See Footnotes Common Stock 4032907 I See Footnotes Common Stock 2755541 I See Footnotes Common Stock 87455 I See Footnotes These securities are beneficially owned by MonoLine Partners, L.P. ("MonoLine"). These securities are owned, as indicated, by MonoLine, MRX Partners, LLC ("MRX Partners"), MonoLine Rx, L.P. ("Monoline Rx"), MonoLine Rx II, L.P. ("Monoline II"), and MonoLine Rx III, L.P. ("Monoline III"), respectively. Monoline, MRX Partners, Monoline Rx, Monoline II, and Monoline III are referred to herein collectively as the "Monoline Entities". Bratton Capital Management, L.P. ("Bratton Capital Management") is the general partner of each of the Monoline Entities. Bratton Capital, Inc. ("Bratton") is the general partner of Bratton Capital Management. The Reporting Person, Douglas K. Bratton, is the sole director of Bratton and has voting and investment power over all shares held by the Monoline Entities. These securities are beneficially owned by MRX Partners. These securities are beneficially owned by Monoline Rx. These securities are beneficially owned by Monoline II. These securities are beneficially owned by Monoline III. These securities are beneficially owned by MonoSol Rx Genpar, L.P. ("Monosol"). Bratton is the general partner of Monosol. The Reporting Person, Douglas K. Bratton, is the sole director of Bratton and has voting and investment power over all shares held by Monosol. Bratton Capital Management, Bratton, and Mr. Bratton may each be deemed to own beneficially all shares owned by the Monoline Entities, and Bratton and Mr. Bratton may be deemed to beneficially own all shares held by Monosol. Each such entity and Mr. Bratton disclaims beneficial ownership of the reported securities except to the extent of its or his respective pecuniary interest therein. /s/ Douglas K. Bratton 2018-07-26 /s/ John Cochran, Vice President of Bratton Capital, Inc., general partner of Bratton Capital Management, L.P., general partner of MonoLine Partners, L.P. 2018-07-26 /s/ John Cochran, Vice President of Bratton Capital, Inc., general partner of Bratton Capital Management, L.P. 2018-07-26 /s/ John Cochran, Vice President of Bratton Capital, Inc. 2018-07-26